Wallace Max N. 4
4 · Humacyte, Inc. · Filed Jun 13, 2022
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Wallace Max N.
Director
Transactions
- Award
Stock Options (right to buy)
[F1]2022-06-09+8,500→ 8,500 totalExercise: $4.34Exp: 2032-06-09→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.
Signature
/s/ Max N. Wallace by Dale A. Sander as Attorney-in-Fact|2022-06-13